Enrolling
Filter By:
Start-up
CTNPT 051: MindMap Feasibility Study
Optimizing HIV prevention for sexual and gender minorities seeking mental health supports: A feasibility study
Learn MoreReporting
CTN 334: Sex Now / Test Now 2022
Barriers and Facilitators of the “Sex Now 2022” Venue-Based HIV Self-Testing and Peer-Based Linkage to Care Intervention for Sexual Minority Men, Non-Binary, and Two-Spirit People
Learn MoreCompleted
CTNPT 018: Adaptation and pilot of GPS among Latino gay positive men
Cultural Adaptation of Gay Poz Sex (GPS): A Positive Prevention Program for Gay, HIV-Positive Latino Men in Canada and Colombia
Learn MoreEnrolling
CTN 335: The British Columbia CARMA–CHIWOS Collaboration (BCC3)
The role of female sex hormones and chronic/latent co-infections on cellular aging and comorbidities in women living with HIV
Learn MoreEnrolling
CTN 318: Sexual Confidence Randomized Controlled Trial
Integrating cognitive-behavioural therapy for social anxiety disorder with HIV risk reduction counselling for HIV-negative gay and bisexual men who are at high risk for HIV
Learn MoreEnrolling
CTN 287: OPT-IN
Optimizing the delivery of HIV post-exposure prophylaxis: A randomized controlled trial of text messaging support and physician to nurse task-shifting
Learn MoreCompleted
CTN 276: The SPOT Project
Motivational Interviewing in Conjunction with Rapid HIV Testing
Learn MoreReporting
CTN 271: Gay Poz Sex
A small group intervention to reduce HIV sexual transmission risk behaviour among HIV-positive men who have sex with men: Gay Positive Sex (GPS)
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.